Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery
Recruiting
N/A
Interventional Study
Analgesia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 172 (estimated)
- Sponsor
- National Cancer Institute, Egypt · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regarding pain control and possible side effects.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients scheduled for modified radical mastectomy,
* Age 18-65 years,
* ASA I-II
Exclusion Criteria:
* patient refusal,
* coagulation defects,
* abnormal kidney or liver functions,
* local infection at site of injection.
Contacts